Cólera

Sack DA, Sack RB, Nair GB, et al. Cholera. Lancet. 2004 Jan 17;363(9404):223-33. Resumo

World Health Organization. Fact sheet: cholera. Dec 2023 [internet publication].Texto completo

1. Kanungo S, Azman AS, Ramamurthy T, et al. Cholera. Lancet. 2022 Apr 9;399(10333):1429-40. Resumo

2. Centers for Disease Control and Prevention. CDC Yellow Book 2024: health information for international travel. Section 5: travel-associated infections & diseases​ - cholera. May 2023 [internet publication].Texto completo

3. Sack DA, Sack RB, Nair GB, et al. Cholera. Lancet. 2004 Jan 17;363(9404):223-33. Resumo

4. Centers for Disease Control and Prevention. Laboratory testing for cholera. Nov 2022 [internet publication].Texto completo

5. Siddique AK, Nair GB, Alam M, et al. El Tor cholera with severe disease: a new threat to Asia and beyond. Epidemiol Infect. 2010 Mar;138(3):347-52. Resumo

6. World Health Organization. Fact sheet: cholera. Dec 2023 [internet publication].Texto completo

7. Diop SA, Manga NM, Dia NM, et al. Cholera and pregnancy: epidemiological, clinical, and evolutionary aspects [in French]. Med Mal Infect. 2007 Dec;37(12):816-20. Resumo

8. Tran NT, Taylor R, Antierens A, et al. Cholera in pregnancy: a systematic review and meta-analysis of fetal, neonatal, and maternal mortality. 2015 Jul 15;10(7):e0132920.Texto completo  Resumo

9. World Health Organization. Cholera, 2015. Wkly Epidemiol Rec. 2016 Sep 23;91(38):433-40.Texto completo  Resumo

10. Ali M, Lopez AL, You YA, et al. The global burden of cholera. Bull World Health Organ. 2012 Mar 1;90(3):209-18A.Texto completo  Resumo

11. World Health Organisation. Cholera 2022. Weekly epidemiological record 9. 2022 Sep 22;8(‎38)‎:431-52.Texto completo

12. Larkin H. WHO report: cholera resurgent in 2022 after years of decline. JAMA. 2023 Jan 17;329(3):200.

13. Zuckerman JN, Rombo L, Fisch A. The true burden and risk of cholera: implications for prevention and control. Lancet Infect Dis. 2007 Aug;7(8):521-30. Resumo

14. Ali M, Nelson AR, Lopez AL, et al. Updated global burden of cholera in endemic countries. PLoS Negl Trop Dis. 2015 Jun 4;9(6):e0003832. Resumo

15. Emch M, Feldacker C, Islam MS, et al. Seasonality of cholera from 1974 to 2005: a review of global patterns. Int J Health Geogr. 2008 Jun 1;7:31.Texto completo  Resumo

16. Griffith DC, Kelly-Hope LA, Miller MA. Review of reported cholera outbreaks worldwide, 1995-2005. Am J Trop Med Hyg. 2006 Nov;75(5):973-7.Texto completo  Resumo

17. World Health Organization. Disease oubreak news: cholera - Haiti. Dec 2022 [internet publication].Texto completo

18. Vega Ocasio D, Juin S, Berendes D, et al. Cholera outbreak - Haiti, september 2022-january 2023. MMWR Morb Mortal Wkly Rep. 2023 Jan 13;72(2):21-5.Texto completo  Resumo

19. World Health Organization. Cholera, 2018. Wkly Epidemiol Rec. 2019 Nov 29;94(48):561-80.

20. World Health Organization. Cholera, 2007. Wkly Epidemiol Rec. 2008 Aug 1;83(31):269-83. Resumo

21. Mahalanabis D, Faruque AS, Albert MJ, et al. An epidemic of cholera due to Vibrio cholerae O139 in Dhaka, Bangladesh: clinical and epidemiological features. Epidemiol Infect. 1994 Jun;112(3):463-71. Resumo

22. Morris JG Jr. Cholera and other types of vibriosis: a story of human pandemics and oysters on the half shell. Clin Infect Dis. 2003 Jul 15;37(2):272-80.Texto completo  Resumo

23. Li M, Shimada T, Morris JG Jr, et al. Evidence for the emergence of non-O1 and non-O139 Vibrio cholerae strains with pathogenic potential by exchange of O-antigen biosynthesis regions. Infect Immun. 2002 May;70(5):2441-53.Texto completo  Resumo

24. Engel MF, Muijsken MA, Mooi-Kokenberg E, et al. Vibrio cholerae non-O1 bacteraemia: description of three cases in the Netherlands and a literature review. Euro Surveill. 2016 Apr 14;21(15).Texto completo  Resumo

25. Holbourn KP, Shone CC, Acharya KR. A family of killer toxins: exploring the mechanism of ADP-ribosylating toxins. FEBS J. 2006 Oct;273(20):4579-93.Texto completo  Resumo

26. Paneth N. Assessing the contributions of John Snow to epidemiology: 150 years after removal of the broad street pump handle. Epidemiology. 2004 Sep;15(5):514-6. Resumo

27. Ries AA, Vugia DJ, Beingolea L, et al. Cholera in Piura, Peru: a modern urban epidemic. J Infect Dis. 1992 Dec;166(6):1429-33. Resumo

28. Motarjemi Y, Käferstein F, Moy G, et al. Contaminated weaning food: a major risk factor for diarrhoea and associated malnutrition. Bull World Health Organ. 1993;71(1):79-92.Texto completo  Resumo

29. Gundry S, Wright J, Conroy R. A systematic review of the health outcomes related to household water quality in developing countries. J Water Health. 2004 Mar;2(1):1-13. Resumo

30. Wright J, Gundry S, Conroy R. Household drinking water in developing countries: a systematic review of microbiological contamination between source and point-of-use. Trop Med Int Health. 2004 Jan;9(1):106-17.Texto completo  Resumo

31. Rabbani GH, Greenough WB 3rd. Food as a vehicle of transmission of cholera. J Diarrhoeal Dis Res. 1999 Mar;17(1):1-9. Resumo

32. Albert MJ. Epidemiology and molecular biology of Vibrio cholerae O139 Bengal. Indian J Med Res. 1996 Jul;104:14-27. Resumo

33. Hashizume M, Wagatsuma Y, Faruque AS, et al. Factors determining vulnerability to diarrhoea during and after severe floods in Bangladesh. J Water Health. 2008 Sep;6(3):323-32. Resumo

34. Evans CA, Gilman RH, Rabbani GH, et al. Gastric acid secretion and enteric infection in Bangladesh. Trans R Soc Trop Med Hyg. 1997 Nov-Dec;91(6):681-5. Resumo

35. Nalin DR, Levine RJ, Levine MM, et al. Cholera, non-vibrio cholera, and stomach acid. Lancet. 1978 Oct 21;2(8095):856-9. Resumo

36. Richterman A, Sainvilien DR, Eberly L, et al. Individual and household risk factors for symptomatic cholera infection: a systematic review and meta-analysis. J Infect Dis. 2018 Oct 15;218(suppl 3):S154-64.Texto completo  Resumo

37. Berger SA, Young NA, Edberg SC. Relationship between infectious diseases and human blood type. Eur J Clin Microbiol Infect Dis. 1989 Aug;8(8):681-9. Resumo

38. Cohen MB, Giannella RA, Losonsky GA, et al. Validation and characterization of a human volunteer challenge model for cholera by using frozen bacteria of the new Vibrio cholerae epidemic serotype, O139. Infect Immun. 1999 Dec;67(12):6346-9.Texto completo  Resumo

39. Harris JB, Khan AI, LaRocque RC, et al. Blood group, immunity, and risk of infection with Vibrio cholerae in an area of endemicity. Infect Immun. 2005 Nov;73(11):7422-7.Texto completo  Resumo

40. Palmer DL, Koster FT, Alam AK, et al. Nutritional status: a determinant of severity of diarrhea in patients with cholera. J Infect Dis. 1976 Jul;134(1):8-14. Resumo

41. von Seidlein L, Wang XY, Macuamule A, et al. Is HIV infection associated with an increased risk for cholera? Findings from a case-control study in Mozambique. Trop Med Int Health. 2008 May;3(5):683-8.Texto completo  Resumo

42. Colombara DV, Cowgill KD, Faruque AS. Risk factors for severe cholera among children under five in rural and urban Bangladesh, 2000-2008: a hospital-based surveillance study. PLoS One. 2013;8(1):e54395.Texto completo  Resumo

43. World Health Organization. Ending cholera: a global roadmap to 2030. Oct 2017 [internet publication].Texto completo

44. Global Task Force on Cholera Control. Cholera outbreak response: field manual. 2024 ​[internet publication].Texto completo

45. World Health Organization. Fact sheet: sanitation. Mar 2024 [internet publication].Texto completo

46. Saif-Ur-Rahman KM, Mamun R, Hasan M, et al. Oral killed cholera vaccines for preventing cholera. Cochrane Database Syst Rev. 2024 Jan 10;1(1):CD014573.Texto completo  Resumo

47. Saha A, Chowdhury MI, Khanam F, et al. Safety and immunogenicity study of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine Shanchol, in Bangladeshi adults and children as young as 1 year of age. Vaccine. 2011 Oct 26;29(46):8285-92. Resumo

48. Sur D, Kanungo S, Sah B, et al. Efficacy of a low-cost, inactivated whole-cell oral cholera vaccine: results from 3 years of follow-up of a randomized, controlled trial. PLoS Negl Trop Dis. 2011 Oct;5(10):e1289.Texto completo  Resumo

49. Phares CR, Date K, Travers P, et al. Mass vaccination with a two-dose oral cholera vaccine in a long-standing refugee camp, Thailand. Vaccine. 2016 Jan 2;34(1):128-33.Texto completo  Resumo

50. Qadri F, Ali M, Chowdhury F, et al. Feasibility and effectiveness of oral cholera vaccine in an urban endemic setting in Bangladesh: a cluster randomised open-label trial. Lancet. 2015 Oct 3;386(10001):1362-71. Resumo

51. Harris JB, LaRocque RC, Qadri F, et al. Cholera. Lancet. 2012 Jun 3;379(9835):2466-76.Texto completo  Resumo

52. Clemens JD, Nair GB, Ahmed T, et al. Cholera. Lancet. 2017 Sep 23;390(10101):1539-49. Resumo

53. Bi Q, Ferreras E, Pezzoli L, et al. Protection against cholera from killed whole-cell oral cholera vaccines: a systematic review and meta-analysis. Lancet Infect Dis. 2017 Oct;17(10):1080-8.Texto completo  Resumo

54. Hill DR, Ford L, Lalloo DG. Oral cholera vaccines: use in clinical practice. Lancet Infect Dis. 2006 Jun;6(6):361-73. Resumo

55. Sur D, Lopez AL, Kanungo S, et al. Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial. Lancet. 2009 Nov 14;374(9702):1694-702. Resumo

56. Masuet Aumatell C, Ramon Torrell JM, Zuckerman JN. Review of oral cholera vaccines: efficacy in young children. Infect Drug Resist. 2011 Sep 14;4:155-60.Texto completo  Resumo

57. Das JK, Tripathi A, Ali A, et al. Vaccines for the prevention of diarrhea due to cholera, shigella, ETEC and rotavirus. BMC Public Health. 2013 Sep 17;13(suppl 3):S11.Texto completo  Resumo

58. Bhattacharya SK, Sur D, Ali M, et al. 5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomised, double-blind, placebo-controlled trial. Lancet Infect Dis. 2013 Dec;13(12):1050-6. Resumo

59. Lopez AL, Deen J, Azman AS, et al. Immunogenicity and protection from a single dose of internationally available killed oral cholera vaccine: a systematic review and metaanalysis. Clin Infect Dis. 2018 Jun 1;66(12):1960-71.Texto completo  Resumo

60. World Health Organization. Cholera vaccine: WHO position paper, August 2017 - recommendations. Vaccine. 2018 Jun 7;36(24):3418-20. Resumo

61. Martin S, Lopez AL, Bellos A, et al. Post-licensure deployment of oral cholera vaccines: a systematic review. Bull World Health Organ. 2014 Dec 1;92(12):881-93.Texto completo  Resumo

62. Ali M, Sur D, You YA, et al. Herd protection by a bivalent killed whole-cell oral cholera vaccine in the slums of Kolkata, India. Clin Infect Dis. 2013 Apr;56(8):1123-31.Texto completo  Resumo

63. International Medical Corps (IMC) & International Rescue Committee (IRC). Guidance note on the use of oral cholera vaccines. Mar 2016 [internet publication].Texto completo

64. Centers for Disease Control and Prevention. Traveler's health: cholera information for health care professionals. Aug 2023 [internet publication].Texto completo

65. Libman M, CATMAT. Summary of the Committee to Advise on Tropical Medicine and Travel (CATMAT) statement on travellers' diarrhea. Can Commun Dis Rep. 2015 Nov 5;41(11):272-84.Texto completo  Resumo

66. Centers for Disease Control and ​Prevention. Cholera - Vibrio cholerae infection: vaccines. Aug 2023 [internet publication].Texto completo

67. Collins JP, Ryan ET, Wong KK, et al. Cholera vaccine: recommendations of the advisory committee on immunization practices, 2022. MMWR Morb Mortal Wkly Rep. Sep 2022;71(2):1–8Texto completo

68. Chen WH, Cohen MB, Kirkpatrick BD, et al. Single-dose live oral cholera vaccine CVD 103-HgR protects against human experimental infection with Vibrio cholerae O1 El Tor. Clin Infect Dis. 2016 Jun 1;62(11):1329-35.Texto completo  Resumo

69. Cabrera A, Lepage JE, Sullivan KM, et al. Vaxchora: a single-dose oral cholera vaccine. Ann Pharmacother. 2017 Jul;51(7):584-9. Resumo

70. Graves PM, Deeks JJ, Demicheli V, et al. Vaccines for preventing cholera: killed whole cell or other subunit vaccines (injected). Cochrane Database Syst Rev. 2010 Aug 4;(8):CD000974.Texto completo  Resumo

71. Vugia DJ, Rodriguez M, Vargas R, et al. Epidemic cholera in Trujillo, Peru 1992: utility of a clinical case definition and shift in Vibrio cholerae O1 serotype. Am J Trop Med Hyg. 1994 May;50(5):566-9. Resumo

72. Swerdlow DL, Ries AA. Cholera in the Americas. Guidelines for the clinician. JAMA. 1992 Mar 18;267(11):1495-9. Resumo

73. Kaushik JS, Gupta P, Faridi MM, et al. Single dose azithromycin versus ciprofloxacin for cholera in children: a randomized controlled trial. Indian Pediatr. 2010 Apr;47(4):309-15. Resumo

74. Chatterjee A, Mahalanabis D, Jalan KN, et al. Plasma specific gravity and haematocrit values as indices of the degree of dehydration in infantile diarrhoea. Indian J Med Res. 1979 Aug;70:229-32. Resumo

75. Cook GC. Gastroenterological emergencies in the tropics. Baillieres Clin Gastroenterol. 1991 Dec;5(4):861-86. Resumo

76. Wang F, Butler T, Rabbani GH, et al. The acidosis of cholera. Contributions of hyperproteinemia, lactic acidemia, and hyperphosphatemia to an increased serum anion gap. N Engl J Med. 1986 Dec 18;315(25):1591-5. Resumo

77. Nato F, Boutonnier A, Rajerison M, et al. One-step immunochromatographic dipstick tests for rapid detection of Vibrio cholerae O1 and O139 in stool samples. Clin Vaccine Immunol. 2003 May;10(3):476-8.Texto completo  Resumo

78. Ramamurthy T, Pal A, Bag PK, et al. Detection of cholera toxin gene in stool specimens by polymerase chain reaction: comparison with bead enzyme-linked immunosorbent assay and culture method for laboratory diagnosis of cholera. J Clin Microbiol. 1993 Nov;31(11):3068-70.Texto completo  Resumo

79. Mandell, GL, Bennett JE, Dolin R. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. 6th ed. New York, NY: Elsevier/Churchill Livingstone; 2005.

80. Mundy LS, Shanholtzer CJ, Willard KE, et al. An evaluation of three commercial fecal transport systems for the recovery of enteric pathogens. Am J Clin Pathol. 1991 Sep;96(3):364-7. Resumo

81. Harris JR, Cavallaro EC, de Nobrega AA, et al. Field evaluation of crystal VC(R) rapid dipstick test for cholera during a cholera outbreak in Guinea-Bissau. Trop Med Int Health. 2009 Sep;114(9):1117-21. Resumo

82. Mehrabadi JF, Morsali P, Nejad HR, et al. Detection of toxigenic Vibrio cholerae with new multiplex PCR. J Infect Public Health. 2012 Jun;5(3):263-7.Texto completo  Resumo

83. Ramamurthy T, Das B, Chakraborty S, et al. Diagnostic techniques for rapid detection of Vibrio cholerae O1/O139. Vaccine. 2020 Feb 29;38 Suppl 1:A73-82.Texto completo  Resumo

84. Chamanrokh P, Colwell RR, Huq A. Loop-mediated isothermal amplification (LAMP) assay for rapid detection of viable but non-culturable Vibrio cholerae O1. Can J Microbiol. 2022 Feb;68(2):103-10. Resumo

85. Yamazaki W. Sensitive and rapid detection of cholera toxin-producing Vibrio cholerae using loop-mediated isothermal amplification. Methods Mol Biol. 2011;739:13-22. Resumo

86. Ryan U, Paparini A, Oskam C. New technologies for detection of enteric parasites. Trends Parasitol. 2017 Jul;33(7):532-46. Resumo

87. Li J. Cholera. In: Li, H. Radiology of Infectious Diseases: volume 2. Netherlands: Springer; 2015:75-82.

88. Saha D, Karim MM, Khan WA, et al. Single-dose azithromycin for the treatment of cholera in adults. N Engl J Med. 2006 Jun 8;354(23):2452-62.Texto completo  Resumo

89. Weil AA, Khan AI, Chowdhury F, et al. Clinical outcomes in household contacts of patients with cholera in Bangladesh. Clin Infect Dis. 2009 Nov 15;49(10):1473-9.Texto completo  Resumo

90. Alam M, Hasan NA, Sultana M, et al. Diagnostic limitations to accurate diagnosis of cholera. J Clin Microbiol. 2010 Nov;48(11):3918-22. Resumo

91. WHO Global Task Force on Cholera Control. Acute diarrhoeal diseases in complex emergencies: critical steps. 2010 [internet publication].Texto completo

92. World Health Organization. The WHO Global Clinical Platform forms to support the case management of cholera. Feb 2023 [internet publication].Texto completo

93. Musekiwa A, Volmink J. Oral rehydration salt solution for treating cholera: <= 270 mOsm/L solutions vs >= 310 mOsm/L solutions. Cochrane Database Syst Rev. 2011 Dec 7;(12):CD003754.Texto completo  Resumo

94. Gregorio GV, Gonzales ML, Dans LF, et al. Polymer-based oral rehydration solution for treating acute watery diarrhoea. Cochrane Database Syst Rev. 2016 Dec 13;(12):CD006519.Texto completo  Resumo

95. Leibovici-Weissman Y, Neuberger A, Bitterman R, et al. Antimicrobial drugs for treating cholera. Cochrane Database Syst Rev. 2014 Jun 19;(6):CD008625.Texto completo  Resumo

96. Nelson EJ, Nelson DS, Salam MA, et al. Antibiotics for both moderate and severe cholera. N Engl J Med. 2011 Jan 6;364(1):5-7.Texto completo  Resumo

97. Centers for Disease Control and Prevention. Recommendations for the use of antibiotics for the treatment of cholera. Jun 2022 [internet publication].Texto completo

98. Global Task Force on Cholera Control. ​Use of antibiotics for the treatment and control of cholera. Oct 2022 [internet publication].Texto completo

99. Cross R, Ling C, Day NP, et al. Revisiting doxycycline in pregnancy and early childhood--time to rebuild its reputation? Expert Opin Drug Saf. 2016;15(3):367-82.Texto completo  Resumo

100. Rusu A, Munteanu AC, Arbănași EM, et al. Overview of side-effects of antibacterial fluoroquinolones: new drugs versus old drugs, a step forward in the safety profile? Pharmaceutics. 2023 Mar 1;15(3):804.Texto completo  Resumo

101. Alam AN, Alam NH, Ahmed T, et al. Randomised double blind trial of single dose doxycycline for treating cholera in adults. BMJ. 1990 Jun 23;300(6740):1619-21.Texto completo  Resumo

102. Khan WA, Bennish ML, Seas C, et al. Randomised controlled comparison of single-dose ciprofloxacin and doxycycline for cholera caused by Vibrio cholerae O1 or O139. Lancet. 1996 Aug 3;348(9023):296-300. Resumo

103. Roy SK, Hossain MJ, Khatun W, et al. Zinc supplementation in children with cholera in Bangladesh: randomised controlled trial. BMJ. 2008 Feb 2;336(7638):266-8.Texto completo  Resumo

104. Canani RB, Cirillo P, Buccigrossi V, et al. Zinc inhibits cholera toxin-induced, but not Escherichia coli heat-stable enterotoxin-induced, ion secretion in human enterocytes. J Infect Dis. 2005 Apr 1;191(7):1072-7.Texto completo  Resumo

105. World Health Organization. Vitamin A supplementation in infants and children 6-59 months of age. 2011 [internet publication].Texto completo

106. Ghana VAST Study Team. Vitamin A supplementation in northern Ghana: effects on clinic attendances, hospital admissions, and child mortality. Lancet. 1993 Jul 3;342(8862):7-12. Resumo

107. Bhandari N, Bahl R, Sazawal S, et al. Breast-feeding status alters the effect of vitamin A treatment during acute diarrhea in children. J Nutr. 1997 Jan;127(1):59-63.Texto completo  Resumo

108. Imdad A, Mayo-Wilson E, Haykal MR, et al. Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age. Cochrane Database Syst Rev. 2022 Mar 16:3:CD008524.Texto completo  Resumo

109. Utsalo SJ, Eko FO, Umoh F, et al. Faecal excretion of Vibrio cholerae during convalescence of cholera patients in Calabar, Nigeria. Eur J Epidemiol. 1999 Apr;15(4):379-81. Resumo

110. Echevarría J, Seas C, Carrillo C, et al. Efficacy and tolerability of ciprofloxacin prophylaxis in adult household contacts of patients with cholera. Clin Infect Dis. 1995 Jun;20(6):1480-4. Resumo

111. Reveiz L, Chapman E, Ramon-Pardo P, et al. Chemoprophylaxis in contacts of patients with cholera: systematic review and meta-analysis. PLoS One. 2011 Nov 15;6(11):e27060.Texto completo  Resumo